Piper Jaffray Companies Boosts Danaher (NYSE:DHR) Price Target to $153.00

Danaher (NYSE:DHR) had its price objective lifted by Piper Jaffray Companies from $148.00 to $153.00 in a research note issued to investors on Thursday, The Fly reports. They currently have a neutral rating on the conglomerate’s stock. Piper Jaffray Companies also issued estimates for Danaher’s Q2 2019 earnings at $1.19 EPS, Q3 2019 earnings at $1.16 EPS, Q4 2019 earnings at $1.37 EPS, FY2019 earnings at $4.79 EPS, Q2 2020 earnings at $1.38 EPS, Q3 2020 earnings at $1.33 EPS and Q4 2020 earnings at $1.55 EPS.

A number of other brokerages have also weighed in on DHR. Zacks Investment Research lowered GALP ENERGIA SG/ADR from a hold rating to a sell rating in a research report on Monday, May 6th. Needham & Company LLC reissued a buy rating and issued a $150.00 target price (up previously from $135.00) on shares of Veeva Systems in a research report on Wednesday, April 17th. Wolfe Research assumed coverage on Waters in a research report on Thursday, May 30th. They issued an underperform rating for the company. Finally, Janney Montgomery Scott boosted their target price on Danaher from $136.00 to $174.00 and gave the stock a buy rating in a research report on Wednesday, April 17th. Three analysts have rated the stock with a hold rating and ten have given a buy rating to the company. The company presently has an average rating of Buy and a consensus price target of $139.08.

Shares of NYSE:DHR opened at $141.61 on Thursday. Danaher has a fifty-two week low of $94.59 and a fifty-two week high of $145.50. The stock has a 50-day simple moving average of $140.27. The company has a current ratio of 2.18, a quick ratio of 1.74 and a debt-to-equity ratio of 0.32. The stock has a market cap of $101.38 billion, a price-to-earnings ratio of 31.33, a price-to-earnings-growth ratio of 2.56 and a beta of 0.96.

Danaher (NYSE:DHR) last issued its earnings results on Thursday, July 18th. The conglomerate reported $1.19 earnings per share for the quarter, topping the Zacks’ consensus estimate of $1.15 by $0.04. Danaher had a return on equity of 11.73% and a net margin of 12.22%. The business had revenue of $5.16 billion during the quarter, compared to analyst estimates of $5.09 billion. During the same quarter in the previous year, the firm earned $1.15 EPS. Danaher’s revenue was up 3.5% on a year-over-year basis. As a group, sell-side analysts anticipate that Danaher will post 4.77 EPS for the current year.

The firm also recently declared a quarterly dividend, which will be paid on Friday, July 26th. Stockholders of record on Friday, June 28th will be given a dividend of $0.17 per share. This represents a $0.68 annualized dividend and a dividend yield of 0.48%. The ex-dividend date is Thursday, June 27th. Danaher’s payout ratio is currently 15.04%.

In other news, SVP William King sold 12,950 shares of the company’s stock in a transaction dated Wednesday, May 29th. The shares were sold at an average price of $129.92, for a total transaction of $1,682,464.00. Following the completion of the sale, the senior vice president now owns 29,070 shares of the company’s stock, valued at approximately $3,776,774.40. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Alan G. Spoon sold 1,913 shares of the company’s stock in a transaction dated Wednesday, April 24th. The shares were sold at an average price of $129.52, for a total transaction of $247,771.76. Following the sale, the director now directly owns 86,863 shares of the company’s stock, valued at approximately $11,250,495.76. The disclosure for this sale can be found here. Insiders have sold a total of 453,448 shares of company stock valued at $59,724,640 in the last ninety days. Insiders own 11.40% of the company’s stock.

Hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Private Vista LLC bought a new position in shares of Danaher during the 2nd quarter valued at approximately $222,000. Pioneer Trust Bank N A OR grew its stake in shares of Danaher by 1.0% during the 2nd quarter. Pioneer Trust Bank N A OR now owns 52,591 shares of the conglomerate’s stock valued at $7,516,000 after acquiring an additional 520 shares during the period. JGP Global Gestao de Recursos Ltda. bought a new position in shares of Danaher during the 2nd quarter valued at approximately $521,000. Meridian Financial Partners LLC grew its stake in shares of Danaher by 3.0% during the 2nd quarter. Meridian Financial Partners LLC now owns 2,847 shares of the conglomerate’s stock valued at $411,000 after acquiring an additional 83 shares during the period. Finally, FDx Advisors Inc. grew its stake in shares of Danaher by 28.8% during the 2nd quarter. FDx Advisors Inc. now owns 19,932 shares of the conglomerate’s stock valued at $2,849,000 after acquiring an additional 4,453 shares during the period. 78.82% of the stock is owned by hedge funds and other institutional investors.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company's Life Sciences segment provides mass spectrometers; cellular analysis, lab automation, and centrifugation instruments; microscopes; and genomics consumables.

Further Reading: What is a management fee?

The Fly

Analyst Recommendations for Danaher (NYSE:DHR)

Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.